Treatment with fractionated (high dose) radiotherapy has been shown to up-regulate the expression of PD-L1 in in vitro glioblastoma cell lines [87], and anti-PD1 treatment is effective particularly in combination with radiotherapy in glioma models [85]. Here, PDCD1 is linked to glioblastoma.